Efficacy of Once Weekly Dulaglutide Compared with Twice-Daily Exenatide in Patients with Type 2 Diabetes: A Post-Hoc Analysis to Determine the Influence of Baseline HbA1c

Authors :: Steve Bain
O. Adetunji
Zachary Skrivanek
Valeria Pechtner
Arash Tahbaz
Source :: Canadian Journal of Diabetes. 38:S52
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: medicine.medical_specialty
business.industry
Endocrinology, Diabetes and Metabolism
Once weekly
General Medicine
Type 2 diabetes
medicine.disease
Endocrinology
Internal medicine
Post-hoc analysis
Internal Medicine
medicine
Dulaglutide
In patient
business
Baseline (configuration management)
Exenatide
medicine.drug

Full Text Access

Tools